Bayer (LIM:BAYERI1) EPS (Basic): S/.16.96 (TTM As of Dec. 2020)


LIM:BAYERI1 Bayer SA LIM:BAYERI1
13 GF Score
Price S/.20.00
View Full Analysis

What is Bayer EPS (Basic)?

Bayer LIM:BAYERI1 13 EPS (Basic) is S/.16.96 as of Dec. 2020. GuruFocus rates LIM:BAYERI1 with a GF Score™ of 13/100.

Bayer's basic earnings per share (Basic EPS) for the three months ended in Dec. 2020 was S/.0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2020 was S/.16.96.

Bayer's EPS (Diluted) for the three months ended in Dec. 2020 was S/.0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was S/.16.96.

Bayer's EPS without NRI for the three months ended in Dec. 2020 was S/.0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2020 was 10.66.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Bayer  (LIM:BAYERI1) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bayer EPS (Basic) Related Terms

Bayer EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Bayer's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer EPS (Basic) Chart

Bayer Annual Data
Trend Dec18 Dec19 Dec20
EPS (Basic)
6.96 15.76 -44.18

Bayer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Dec20
EPS (Basic) Get a 7-Day Free Trial Premium Member Only 1.88 3.93 5.44 5.71 0.00
LIM:BAYERI1
13GF Score
Bayer SA LIM:BAYERI1
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Bayer's Basic EPS for the fiscal year that ended in Dec. 2020 is calculated as

Basic EPS (A: Dec. 2020 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-43413.487-0)/982.420
=-44.19

Bayer's Basic EPS for the quarter that ended in Dec. 2020 is calculated as

Basic EPS (Q: Dec. 2020 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0-0)/982.420
=0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was S/.16.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of S/.16.96 mean?
Bayer (LIM:BAYERI1) has a EPS (Basic) of S/.16.96 as of Dec. 2020. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bayer and its competitors.
Is Bayer's EPS (Basic) too high?
Bayer's current EPS (Basic) is S/.16.96. Overall, Bayer has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Bayer's EPS (Basic) compare to TARO and TLRY?
Bayer's EPS (Basic) of S/.16.96 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Bayer and its competitors. Bayer's current EPS (Basic) is S/.16.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer stock overvalued right now?
Bayer (LIM:BAYERI1) has a current EPS (Basic) of S/.16.96. The current EPS (Basic) is S/.16.96. Bayer's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Bayer (LIM:BAYERI1), the current EPS (Basic) is S/.16.96 as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bayer Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer SA is a Peru-based company. It is a research company focused on the life sciences. The company operates in various business segments that are Pharmaceuticals, which focuses on prescription products, for cardiology and women's healthcare, and on specialty therapeutics; Consumer Health, which markets mainly nonprescription products in the dermatology, nutritional supplement, analgesic, gastrointestinal, cold, and other; and Crop Science segment which generates maximum revenue, is engaged in development, production, and marketing of seeds, and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. Geographically, the company generates key revenue from the United States of America and the rest from China, Brazil, and other countries.
13GF Score

Get the complete analysis for LIM:BAYERI1

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S/.20.00
Price